Koers Wntresearch AB Nasdaq Stockholm
Aandelen
Biotechnologie & Medisch Onderzoek
slotkoers
Andere beurzen
|
||
- SEK | - |
Omzet 2022 | - | Omzet 2023 | - | Marktkapitalisatie | 36,89 mln. 388 mln. 34,01 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | -30 mln. -316 mln. -27,66 mln. | Nettowinst (verlies) 2023 | -32 mln. -337 mln. -29,51 mln. | EV/omzet 2022 | - |
Nettoliquiditeiten 2022 | 9,92 mln. 104 mln. 9,15 mln. | Nettoliquiditeiten 2023 | 26,88 mln. 283 mln. 24,79 mln. | EV/omzet 2023 | - |
K/w-verhouding 2022 |
-1,24
x | K/w-verhouding 2023 |
-0,87
x | Werknemers | - |
Dividendrendement 2022 * |
-
| Dividendrendement 2023 |
-
| Vrij verhandelbaar | 15,12% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Per Norlén
CEO | Chief Executive Officer | 54 | 10/01 |
Founder | 68 | 24-09-07 | |
Anders Tidfors
DFI | Director of Finance/CFO | - | 11-09-20 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Director/Board Member | 72 | 09-06-15 | |
Founder | 68 | 24-09-07 | |
Chairman | 62 | 01-01-22 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+11,91% | 118 mld. | |
+11,60% | 106 mld. | |
-4,68% | 24,28 mld. | |
-0,82% | 21,96 mld. | |
-10,12% | 18,16 mld. | |
-42,12% | 16,37 mld. | |
-17,47% | 15,56 mld. | |
+2,77% | 13,63 mld. | |
+34,58% | 12,27 mld. |